Australia markets closed

Cardiovascular Systems, Inc. (CSII)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
40.24+0.40 (+1.00%)
At close: 4:00PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 51.62B
Enterprise value 31.42B
Trailing P/E N/A
Forward P/E 1-574.86
PEG ratio (5-yr expected) 1-2.34
Price/sales (ttm)7.08
Price/book (mrq)5.91
Enterprise value/revenue 36.20
Enterprise value/EBITDA 6-124.30

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 36.15%
S&P500 52-week change 339.88%
52-week high 348.28
52-week low 326.00
50-day moving average 343.16
200-day moving average 338.80

Share statistics

Avg vol (3-month) 3248.41k
Avg vol (10-day) 3192.03k
Shares outstanding 540.19M
Float 38.8M
% held by insiders 13.03%
% held by institutions 192.89%
Shares short (11 Feb 2021) 41.44M
Short ratio (11 Feb 2021) 45.69
Short % of float (11 Feb 2021) 45.21%
Short % of shares outstanding (11 Feb 2021) 43.59%
Shares short (prior month 14 Jan 2021) 41.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 325 Feb 2009

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin -8.84%
Operating margin (ttm)-6.41%

Management effectiveness

Return on assets (ttm)-3.19%
Return on equity (ttm)-9.68%

Income statement

Revenue (ttm)228.43M
Revenue per share (ttm)6.23
Quarterly revenue growth (yoy)-6.10%
Gross profit (ttm)187.79M
EBITDA -11.39M
Net income avi to common (ttm)-20.19M
Diluted EPS (ttm)-0.55
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)225.06M
Total cash per share (mrq)5.6
Total debt (mrq)23.15M
Total debt/equity (mrq)8.45
Current ratio (mrq)6.09
Book value per share (mrq)6.81

Cash flow statement

Operating cash flow (ttm)-11.45M
Levered free cash flow (ttm)-8.33M